Dose Ranging Study of Albiglutide in Japanese Subjects

NCT01098461 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

215

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

BIOLOGICAL: albiglutide
BIOLOGICAL: placebo

Sponsor

GlaxoSmithKline